Sensus Healthcare Sells SRT System to Providence Swedish Hospital
Continues customer expansion to hospital oncology departments for the outpatient treatment of non-melanoma skin cancers BOCA RATON, Fla. (September 25, 2024) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces it has shipped an SRT system to Providence Swedish […]
Sensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second Quarter
Revenues of $9.2 million compare with $4.5 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $2.1 million compares with negative $1.0 million a year ago “Fair Deal Agreement” recurring revenue program gaining momentum with 15 agreements signed to date Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (August […]
Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024
BOCA RATON, Fla. (August 1, 2024) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, reminds inestors that management will hold a conference call on Thursday, August 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the second […]
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
BOCA RATON, Fla. (April 18, 2024) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter […]
AAD Annual Meeting
Join Sensus Healthcare at the AAD Annual Meeting at the Boston Convention & Exhibition Center! We will be located in booth #4063. Registration is Now Open. Register Here Today! & Exhibition Center!
BioFlorida Announces Five New Board Members
Life Science Leaders Unite To Advance the Industry in Florida WEST PALM BEACH, Fla., Aug. 11, 2021 /PRNewswire/ — BioFlorida has announced five new board members who will support the organization’s effort to grow the life sciences industry in Florida. “The life sciences industry in Florida is vibrant, and we’re excited to welcome Thomas Equels of AIM ImmunoTech, Mark Friedman, PhD of Axogen, Geoff […]
EDITORIAL: COVID-19 SPIRALING OF FRAILTY IN OLDER ITALIAN PATIENTS
To our valued customers, We wanted to share this editorial entitled, “COVID-19: Spirliang of Frailty in Older Italian Patients” written by A.M. Abbatecola and R. Antonelli-Incalzi. In this article it is highlighted that “due to the rapid spread of the coronavirus in Italy, there seems to be a deadly trend toward mortality with COVID-19 in […]
Technology Networks: Superficial Radio Therapy: A non-surgical Treatment for Non-melanoma Skin Cancers
Skin cancer can be broadly split in to two types: melanoma and non-melanoma. The most common non-melanomas include basal cell carcinoma and squamous cell carcinoma, for which the main treatment is surgery. However, other non-surgical options are emerging, including superficial radiation therapy (SRT), a unique type of photon radiotherapy. To learn more about SRT we […]
Thrive Global – The Future of Healthcare: “Using painless, low-dose radiation that only goes skin deep to destroy cancer cells — without damaging health tissue” with Joseph C. Sardano, CEO of Sensus Healthcare, Inc.
As a part of my series about “The Future of Healthcare” I had the pleasure of interviewing Joseph C. Sardano, Chief Executive Officer, Sensus Healthcare Inc. A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new […]
Modern Medicine – Dr. Brian Berman discusses the problem with keloids.
Researchers found in a retrospective study of 297 surgically excised keloids with superficial radiation therapy around the excision site that only 3% recurred during an average 6-month follow-up. Read the full article here.
